{"DataElement":{"publicId":"3008193","version":"2","preferredName":"Disease or Disorder Status Amyloidosis Hepatic Status Type","preferredDefinition":"A description of the hepatic status of amyloidosis.","longName":"2512861v1.0:3008173v1.5","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2512861","version":"1","preferredName":"Disease or Disorder Status","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A condition or state at a particular time.","longName":"2404658v1.0:2320064v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2320064","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC71B93E-037B-5AD9-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B898979-184A-3A90-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3008173","version":"1.5","preferredName":"Amyloidosis Hepatic Status Type","preferredDefinition":"A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands._Pertaining to, affecting, or associated with the liver._A condition or state at a particular time._Something distinguishable as an identifiable class based on common qualities.","longName":"3008173v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not assessed","valueDescription":"Not Done","ValueMeaning":{"publicId":"3104692","version":"1","preferredName":"Not Done","longName":"3104692v1.00","preferredDefinition":"Indicates a task, process or examination that has either not been initiated or not been completed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88084310-6796-6259-E040-BB89AD4311C3","latestVersionIndicator":"Yes","beginDate":"2010-06-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-02","modifiedBy":"RAGUNATHANU","dateModified":"2022-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"91087D01-2B45-6D1A-E053-F662850A9825","beginDate":"2010-02-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-08-26","modifiedBy":"ONEDATA","dateModified":"2019-08-26","deletedIndicator":"No"},{"value":"Not evaluable","valueDescription":"Unevaluable","ValueMeaning":{"publicId":"3153578","version":"1","preferredName":"Unevaluable","longName":"3153578","preferredDefinition":"Unable to be evaluated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unevaluable","conceptCode":"C62222","definition":"Unable to be evaluated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93AC689E-5DB2-5D7A-E040-BB89AD430948","latestVersionIndicator":"Yes","beginDate":"2010-10-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-10-28","modifiedBy":"KUMMEROA","dateModified":"2023-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"91087D01-2B4F-6D1A-E053-F662850A9825","beginDate":"2010-02-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-08-26","modifiedBy":"ONEDATA","dateModified":"2019-08-26","deletedIndicator":"No"},{"value":"Not applicable","valueDescription":"Not applicable","ValueMeaning":{"publicId":"2581003","version":"1","preferredName":"Not applicable","longName":"2581003v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0978-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":"2023.3.6 Added Alt VM-COG. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"91087D01-2B59-6D1A-E053-F662850A9825","beginDate":"2014-03-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-08-26","modifiedBy":"ONEDATA","dateModified":"2019-08-26","deletedIndicator":"No"},{"value":"Hepatic response","valueDescription":"Hepatic response","ValueMeaning":{"publicId":"4241722","version":"1","preferredName":"Hepatic response","longName":"4241722","preferredDefinition":"Greater than or equal to 50% decrease in abnormal alkaline phosphatase value and/or normalization of serum alkaline phosphatase level and decrease in liver size radiographically greater than or equal to 2 cm","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F50E8948-F6F1-57A3-E040-BB89AD436041","latestVersionIndicator":"Yes","beginDate":"2014-03-20","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-03-20","modifiedBy":"COOPERM","dateModified":"2019-08-26","changeDescription":"Changed definition at Angela's request. 8.26.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"91087D01-2B63-6D1A-E053-F662850A9825","beginDate":"2011-02-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-08-26","modifiedBy":"ONEDATA","dateModified":"2019-08-26","deletedIndicator":"No"},{"value":"No response / stable disease","valueDescription":"No response/stable disease","ValueMeaning":{"publicId":"4241721","version":"1","preferredName":"No response/stable disease","longName":"4241721","preferredDefinition":"Does not meet criteria for hepatic response nor hepatic progression.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F50E8948-F6CE-57A3-E040-BB89AD436041","latestVersionIndicator":"Yes","beginDate":"2014-03-20","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-03-20","modifiedBy":"COOPERM","dateModified":"2019-08-26","changeDescription":"Changed definition at Angela's request. 8.26.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"91087D01-2B79-6D1A-E053-F662850A9825","beginDate":"2014-03-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-08-26","modifiedBy":"ONEDATA","dateModified":"2019-08-26","deletedIndicator":"No"},{"value":"Hepatic progression","valueDescription":"Hepatic progression","ValueMeaning":{"publicId":"6864729","version":"1","preferredName":"Hepatic progression","longName":"6864729","preferredDefinition":"Greater than or equal to 50% increase of alkaline phosphatase above the lowest value","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"91087D01-2B9A-6D1A-E053-F662850A9825","latestVersionIndicator":"Yes","beginDate":"2019-08-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-08-26","modifiedBy":"ONEDATA","dateModified":"2019-08-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"91087D01-2BB3-6D1A-E053-F662850A9825","beginDate":"2019-08-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-08-26","modifiedBy":"ONEDATA","dateModified":"2019-08-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3008172","version":"1","preferredName":"Amyloidosis Hepatic Status Type","preferredDefinition":"A group of diseases in which protein is deposited in specific organs (localized amyloidosis) or throughout the body (systemic amyloidosis). Amyloidosis may be either primary (with no known cause) or secondary (caused by another disease, including some types of cancer). Generally, primary amyloidosis affects the nerves, skin, tongue, joints, heart, and liver; secondary amyloidosis often affects the spleen, kidneys, liver, and adrenal glands.:Refers to the liver.:A condition or state at a particular time.:Type; a subdivision of a particular kind of thing.","longName":"C2868:C13308:C25688:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Amyloidosis","conceptCode":"C2868","definition":"A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Hepatic","conceptCode":"C13308","definition":"Pertaining to, affecting, or associated with the liver.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F1B950C-92D4-3010-E040-BB89AD4368F7","latestVersionIndicator":"Yes","beginDate":"2010-02-08","endDate":null,"createdBy":"LOHNESC","dateCreated":"2010-02-08","modifiedBy":"ONEDATA","dateModified":"2010-02-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"91087D01-2B2E-6D1A-E053-F662850A9825","latestVersionIndicator":"Yes","beginDate":"2019-08-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-08-26","modifiedBy":"KUMMEROA","dateModified":"2020-02-03","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964910","version":"1","longName":"2117r1: Amyloidosis Post-HSCT Data","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"PerformedClinicalResult:value ","type":"HCT_BRIDG","context":"NHLBI"},{"name":"amy_post_crnt_hepat_rspns","type":"NMDP_FN","context":"NHLBI"},{"name":"PCDpost_amy_hepatic_stat","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What is the hepatic status of","type":"Preferred Question Text","description":"What is the hepatic status of amyloidosis?","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:3008193","type":"BRIDG Mapping Path","description":"PerformedClinicalResult.value WHERE PerformedClinicalResult > PerformedObservation > DefinedObservation.nameCode = \"assess hepatic function\"","url":null,"context":"NHLBI"},{"name":"Specify the recipient's current hepatic status","type":"Application Standard Question Text","description":"Specify the recipient's current hepatic status","url":null,"context":"NHLBI"},{"name":"Specify the recipient's hepatic status","type":"Alternate Question Text","description":"Specify the recipient's hepatic status","url":null,"context":"NHLBI"},{"name":"Specify the recipient's current hepatic response:","type":"Alternate Question Text","description":"Specify the recipient's current hepatic response:","url":null,"context":"NHLBI"},{"name":"Specify the recipient's current hepatic response","type":"Alternate Question Text","description":"Specify the recipient's current hepatic response","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"91087D01-2BCE-6D1A-E053-F662850A9825","latestVersionIndicator":"Yes","beginDate":"2019-08-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-08-26","modifiedBy":"ZHWENDY","dateModified":"2022-07-20","changeDescription":". System generated def displayed as alt def.; System generated def displayed as alt def.  Added AQT 01/10/2020 KMM","administrativeNotes":"7/20/2022: fixed the box symbol in AQT.wz","unresolvedIssues":null,"deletedIndicator":"No"}}